2023 | Preclinical assessment of rodent jumping power with a novel electrical stimulation-assisted device
| SCIENTIFIC REPORTS |
2023 | Soluble triggering receptor expressed on myeloid cell-1 reflects the cross-sectional activity of microscopic polyangiitis and granulomatosis with polyangiitis
| HELIYON |
2023 | Multiomics Approach to Acromegaly: Unveiling Translational Insights for Precision Medicine
| Endocrinology and Metabolism(대한내분비학회지) |
2023 | Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced non-small cell lung cancer: a phase 1 trial
| NATURE MEDICINE |
2023 | A plain language summary of the results from the group of patients in the CHRYSALIS study with EGFR exon 20 insertion-mutated non-small-cell lung cancer who received amivantamab
| FUTURE ONCOLOGY |
2023 | Comparison of pulmonary vein isolation using cryoballoon, high-power short-duration, and conventional radiofrequency ablation for atrial fibrillation: a propensity score-weighted study
| FRONTIERS IN CARDIOVASCULAR MEDICINE |
2023 | Subtypes of Patients with Mild to Moderate Airflow Limitation as Predictors of Chronic Obstructive Pulmonary Disease Exacerbation
| JOURNAL OF CLINICAL MEDICINE |
2023 | The global, regional, and national burden of inflammatory bowel diseases, 1990-2019: A systematic analysis for the global burden of disease study 2019 | DIGESTIVE AND LIVER DISEASE |
2023 | Relative importance of left atrial reservoir strain compared with components of the HFA-PEFF score: a cross-sectional study
| FRONTIERS IN CARDIOVASCULAR MEDICINE |
2023 | Lazertinib Versus Gefitinib Tyrosine Kinase Inhibitors in Treatment-Naíve Patients With EGFR-Mutated Advanced NSCLC: Analysis of the Asian Subpopulation in LASER301
| JOURNAL OF THORACIC ONCOLOGY |
2023 | A Phase II Study of Osimertinib in Patients with Advanced-Stage Non-Small Cell Lung Cancer following Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR TKI) Therapy with EGFR and T790M Mutations Detected in Plasma Circulating Tumour DNA (PLASMA Study)
| CANCERS |
2023 | Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial
| BMJ-BRITISH MEDICAL JOURNAL |
2023 | Proton pump inhibitor use and the risk of metachronous gastric cancer after H. pylori eradication in patients who underwent endoscopic resection for gastric neoplasms: A population-based cohort study | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
2023 | Impact of a cumulative positive fluid balance during the first three ICU days in patients with sepsis: a propensity score-matched cohort study
| ANNALS OF INTENSIVE CARE |
2023 | Tumor microbiome analysis provides prognostic value for patients with stage III colorectal cancer
| FRONTIERS IN ONCOLOGY |
2023 | Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170)
| FRONTIERS IN ONCOLOGY |
2023 | Association between Impaired Ketogenesis and Metabolic-Associated Fatty Liver Disease
| BIOMOLECULES |
2023 | Everolimus-Eluting Stents or Bypass Surgery for Multivessel Disease in Diabetics: The BEST Extended Follow-Up Study | JACC-CARDIOVASCULAR INTERVENTIONS |
2023 | Engineered small extracellular vesicle-mediated NOX4 siRNA delivery for targeted therapy of cardiac hypertrophy
| JOURNAL OF EXTRACELLULAR VESICLES |
2023 | Long-Term Efficacy and Safety of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria and High Disease Burden: Real-World Data From Korea
| JOURNAL OF KOREAN MEDICAL SCIENCE |